AzTrials
AzTrials

Transversus Abdominis Plane BlockNCT04927624

Transversus Abdominis Plane Block Versus Quoadratus Lumborum Block on Infants

A study testing transversus abdominis plane block and quoadratus lumborum block in people with Transversus Abdominis Plane Block and Quoadratus Lumborum Block, run by Sisli Hamidiye Etfal Training and Research Hospital at 1 site in Turkey (Türkiye).

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

we aimed to compare the effects of TAPB and QLB on postoperative pain score and analgesic consumption in infants who underwent unilateral inguinal hernia surgery. Read more about this study

Who is it for?
Ages 1 month to 12 months
What is being tested?
transversus abdominis plane block and quoadratus lumborum block
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jun 2021to 15 Oct 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 month to 12 months
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • 1 month to 1 year
  • who were scheduled for unilateral inguinal hernia operation
  • American Society of Anesthesiologists (ASA) physical score I-II

Who cannot join

  • Patients with ASA II-IV
  • coagulopathy
  • skin infection at the block application site
  • bupivacaine allergy
  • bilateral inguinal hernia operation
  • additional operation in different region
Show all 9Show fewer
  • laparoscopic inguinal hernia operation
  • younger than 1 month
  • with a history of prematurity

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site, 1 recruiting
  • Sisli Etfal Research and Training Hospital

    Istanbul, 34371

    mustafa altınay, 05333914422, m_altinay@yahoo.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Comparison of Postoperative Analgesic Efficiency of Transversus Abdominis Plane Block and Quoadratus Lumborum Block on Infants Who Underwent Single Sided Inguinal Hernia Repair: A Randomised Controlled Trial

we aimed to compare the effects of TAPB and QLB on postoperative pain score and analgesic consumption in infants who underwent unilateral inguinal hernia surgery.

Read the detailed description

Infants are more sensitive to the side effects of general anesthesia than older children. This may be associated with the incomplete maturation of organ systems effective in pharmacodynamics. Regional anesthesia applications provide safe and effective analgesia by reducing the need for opioids. Regional anesthesia applications in infants require experience and complication rates due to central blocks are high. However, in recent years, the use of ultrasound (USG) has increased the use of safe and effective trunk blocks. There are studies on the use of Transversus Abdominis Plan Block (TAPB) and Quadratus Lumborum Block (QLB) in children. However, there is no comparative study on its use in infants.

In our study, we aimed to compare the effects of TAPB and QLB on postoperative pain score and analgesic consumption in infants who underwent unilateral inguinal hernia surgery.

Being tested
transversus abdominis plane block, quoadratus lumborum block
Keywords
infant, analgesic efficiency, Regional anesthesia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • transversus abdominis plane blockProcedure or surgery

    Also called quoadratus lumborum block

    The transversus abdominis plane (TAP) block was first introduced by Rafi et al. in 2001 as a landmark-guided technique via the triangle of Petit to achieve a field block. It involves the injection of a local anesthetic solution into a plane between the internal oblique muscle and transversus abdominis muscle. Since the thoracolumbar nerves originating from the T6 to L1 spinal roots run into this plane and supply sensory nerves to the anterolateral abdominal wall , the local anesthetic spread in this plane can block the neural afferents and provide analgesia to the anterolateral abdominal wall.

  • quoadratus lumborum blockProcedure or surgery

    quoadratus lumborum block

Study groups in NCT04927624
Study groupRoleWhat they receive
transversus abdominis planeActive comparatorIn the group in which Transversus Abdominis Plan Block was applied, the patient was placed in the supine position. After skin antisepsis was achieved with 10% povidone iodine, the USG probe was placed transversely between the iliac crest and the anterolateral abdominal wall. After visualizing the external-internal obliq and transversus abdominis muscles, 0.5 ml/kg of 0.25% bupivacaine was injected after negative aspiration by advancing the needle into the fascia between the internal obliq muscle and the transversus abdominis muscle with the in-plane technique.
Receives: Procedure: transversus abdominis plane block
quoadratus lumborum blockActive comparatorIn the Quadratus Lumborum Block (Lateral approach) group, the patient was placed in the lateral position with the side to be blocked on top. After skin antisepsis was achieved with 10% povidone iodine, the USG probe was placed transversely between the iliac crest and costa edge. After visualizing the extarnal-internal obliq and transversus abdominis muscles, the probe was advanced posteriorly. Quadratus lumborum muscle and thoracolumbar fascia were visualized. The needle was advanced to the anterolateral border of the quadratus lumborum muscle with the in-plane technique and 0.5 ml/kg of 0.25% bupivacaine was injected after negative aspiration.
Receives: Procedure: quoadratus lumborum block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. FLACC

    Face, Legs, Activitiy, Cry, Consolability score

    Measured: up to 24 hours

  2. first analgesic need times

    time of first analgesic need after surgery

    Measured: up to 24 hours

Secondary outcomes (2)
  1. frequency of need for analgesics

    Frequency of analgesic requirement in the first 24 hours after the operation

    Measured: up to 24 hours

  2. complications

    post-operative anesthetic complications

    Measured: up to 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Jun 2021
  2. Study start1 Jun 2021
  3. Primary completion30 Sep 2021 (estimated)
  4. Study completion15 Oct 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04927624
Sponsor's protocol ID
33334
Status last verified
Jun 2021
First submitted
9 Jun 2021
Last updated
16 Jun 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing transversus abdominis plane block and quoadratus lumborum block in people with Transversus Abdominis Plane Block and Quoadratus Lumborum Block, run by Sisli Hamidiye Etfal Training and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 16 Jun 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

FLACC (time frame: up to 24 hours). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jun 2021; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in